Show
Sort by
-
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
-
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials : recommendations of the SISAQOL Consortium
-
Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer : preliminary analysis of the PePiTA study
-
PCN457 the SISAQOL initiative : establishing international standards and recommendations for the analysis of patient-reported outcomes and quality of life data in oncology randomized clinical trials
-
- Journal Article
- A1
- open access
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer : meta-analysis of individual patient data from ten randomised trials
-
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer : a systematic review
-
- Journal Article
- A1
- open access
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
-
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials